IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
73 hedge funds and large institutions have $768M invested in IVERIC bio, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 12 closing their positions.
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
56% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 18
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
29% more capital invested
Capital invested by funds: $595M → $768M (+$173M)
14% more funds holding
Funds holding: 64 → 73 (+9)
89% less call options, than puts
Call options by funds: $750K | Put options by funds: $7.07M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$40.3M |
| 2 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$32.6M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$22.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$10M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$7.09M |
| 3 |
BC
Broadfin Capital
New York
|
-$4.85M |
| 4 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
-$4M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
-$3.47M |
ISEE Hedge Fund Activity: Q1 2014 in Review
73 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2014, worth a combined $768M — up 29% from $595M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ISEE positions and 12 closed out — a net gain of 10 holders — while 28 added to existing stakes and 18 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $40.3M. The largest seller was Redmile Group, cutting an estimated $10M.
- 73 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2014, up from 64 in Q4 2013.
- Funds reported $768M of IVERIC bio, Inc. Common Stock stock for Q1 2014, up 29% quarter-over-quarter.
- 22 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2014 and 12 closed out, a net change of +10 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2014 was Fidelity Investments, an estimated $40.3M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2014 was Redmile Group, an estimated $10M sold.
Based on aggregated 13F filings for Q1 2014.